Jennifer Taubert, Worldwide Chairman, Pharmaceuticals, joined Johnson & Johnson in 2005 and is a leader in shaping Janssen Pharmaceuticals’ global strategy of transformational medical innovation, successfully commercializing critical new medicines that significantly improve the lives of patients living with cancer, immune-related diseases, heart disease and diabetes, infectious diseases, pulmonary...